Healthcare -
Biotechnology - NASDAQ - US
$ 1.1155
1.68 %
$ 33.7 M
Market Cap
-0.74
P/E
ANTX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ANTX - AN2 Therapeutics, Inc.
372 K
LAST VALUE
-92.73%
2 YEAR CAGR
-45.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR